Dr. Elbert Huang is Professor of Medicine, Director of the Center for Chronic Disease Research and Policy, and Associate Director of the Chicago Center for Diabetes Translation Research at the University of Chicago. From 2010-2011, he served as a Senior Advisor in the Office of the Assistant Secretary for Planning and Evaluation, Department of Health and Human Services.
Dr. Huang is a general internist who studies clinical and health care policy issues at the intersection of diabetes, aging, and health economics. His main research focus is in the area of medical decision making for elderly patients with type 2 diabetes where uncertainty exists regarding how to best individualize diabetes treatments based on clinical parameters and patient preferences. Over the past decade, Dr. Huang has established one of the most active research programs in geriatric diabetes in the country.
Apart from his work in geriatric diabetes, Dr. Huang has also performed other seminal translational diabetes research in the area of cost-effectiveness analysis. He performed the economic analyses of the Health Resources and Services Administration’s Health Disparities Collaboratives initiative of diabetes quality improvement in community health centers that serve the indigent. With this one study, he performed one of the first business case analyses from the perspective of the community health center as well as one of the first societal cost-effectiveness analyses of a quality improvement initiative.
Dr. Huang’s research has been supported by the National Institutes of Health, the Centers for Disease Control and Prevention, the American Diabetes Association, and the Juvenile Diabetes Research Foundation. He has received numerous honors including the Research Paper of the Year Award from the Society of General Internal Medicine and elected membership to the American Society for Clinical Investigation.
Dr. Huang received his A.B., M.D., and M.P.H. from Harvard University and came to the University of Chicago in 2001.
Harvard School of Public Health
Boston, MA
MPH - Clinical Effectiveness
2001
Massachusetts General Hospital
Boston, MA
- Fellow, General Internal Medicine Faculty Development and Fellowship Program
2001
Stanford University Medical Center
Stanford, CA
- Internship and Residency
1999
Harvard Medical School
Boston, MA
MD - Medicine
1996
Harvard College
Cambridge, MA
BA - Biology
1992
The Growing Role of Technology in the Care of Older Adults With Diabetes.
The Growing Role of Technology in the Care of Older Adults With Diabetes. Diabetes Care. 2023 08 01; 46(8):1455-1463.
PMID: 37471606
Expected Health Benefits of SGLT-2 Inhibitors and GLP-1 Receptor Agonists in Older Adults.
Expected Health Benefits of SGLT-2 Inhibitors and GLP-1 Receptor Agonists in Older Adults. MDM Policy Pract. 2023 Jul-Dec; 8(2):23814683231187566.
PMID: 37492502
Use of Real-World Data in Population Science to Improve the Prevention and Care of Diabetes-Related Outcomes.
Use of Real-World Data in Population Science to Improve the Prevention and Care of Diabetes-Related Outcomes. Diabetes Care. 2023 07 01; 46(7):1316-1326.
PMID: 37339346
Reply to: Comment on: Data-driven classification of health status of older adults with diabetes: The diabetes and aging study.
Reply to: Comment on: Data-driven classification of health status of older adults with diabetes: The diabetes and aging study. J Am Geriatr Soc. 2023 Jun 16.
PMID: 37327112
Development and Validation of the Life Expectancy Estimator for Older Adults with Diabetes (LEAD): the Diabetes and Aging Study.
Development and Validation of the Life Expectancy Estimator for Older Adults with Diabetes (LEAD): the Diabetes and Aging Study. J Gen Intern Med. 2023 May 30.
PMID: 37254010
Response to Letter to the Editor by Drs Cook and Stange.
Response to Letter to the Editor by Drs Cook and Stange. Med Care. 2023 Jun 01; 61(6):415.
PMID: 37067980
First-Line Therapy for Type 2 Diabetes With Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists.
First-Line Therapy for Type 2 Diabetes With Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists. Ann Intern Med. 2023 04; 176(4):eL230007.
PMID: 37068291
Data-driven classification of health status of older adults with diabetes: The diabetes and aging study.
Data-driven classification of health status of older adults with diabetes: The diabetes and aging study. J Am Geriatr Soc. 2023 07; 71(7):2120-2130.
PMID: 36883732
Validation of a Hypoglycemia Risk Stratification Tool Using Data From Continuous Glucose Monitors.
Validation of a Hypoglycemia Risk Stratification Tool Using Data From Continuous Glucose Monitors. JAMA Netw Open. 2023 03 01; 6(3):e236315.
PMID: 37000454
Two concurrent randomized controlled trials of CommunityRx, a social care intervention for family and friend caregivers delivered at the point of care.
Two concurrent randomized controlled trials of CommunityRx, a social care intervention for family and friend caregivers delivered at the point of care. Res Sq. 2023 Mar 01.
PMID: 36909590
Award for Leadership
Midwest Region Society of General Internal Medicine
2018
American Society for Clinical Investigation, Elected Member
2011
Mary Tyler Moore and S. Robert Levine, M.D., Excellence in Clinical Research Award
JDRF
2011
Leif B. Sorensen Faculty Research Award
Department of Medicine, University of Chicago
2011
Research Paper of the Year Award
Society of General Internal Medicine
2009
Presidential Poster Session Award (Preventive Medicine)
American Geriatrics Society
2007
Presidential Poster Session Award (Quality of Life)
American Geriatrics Society
2006
Merck New Investigator Award
American Geriatrics Society
2006
Junior Faculty Research Abstract Award
Midwest Society of General Internal Medicine
2001